HH
IRON icon

Hilltop Holdings’s Disc Medicine IRON Stock Holding History

Hilltop Holdings’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-7,100
Closed -$315K – 615
2023
Q2 		$315K Buy
+7,100
New +$252K 0.04% 416

Other funds holding IRON

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Hilltop Holdings's IRON Position: Q3 2023 in Review

Hilltop Holdings sold out of Disc Medicine (IRON) in Q3 2023, closing a stake of 7,100 shares — an estimated $315K sold.

Hilltop Holdings first reported a position in IRON in Q2 2023 and held it in 1 quarter. The position peaked at $315K in Q2 2023. 91 funds tracked by Wall St. Rank hold IRON as of Q3 2023.

  • Hilltop Holdings reported no remaining Disc Medicine position as of Q3 2023 after selling out during the quarter.
  • Hilltop Holdings sold 7,100 Disc Medicine shares in Q3 2023, an estimated $315K.
  • Hilltop Holdings first reported a position in Disc Medicine in Q2 2023 and held it in 1 quarter.
  • Hilltop Holdings's Disc Medicine position peaked at $315K in Q2 2023.
  • 91 funds tracked by Wall St. Rank held Disc Medicine as of Q3 2023.

Based on Hilltop Holdings's 13F filing for Q3 2023, filed 14 Nov 2023.